Randomized cross‐over trial comparing inpatient and outpatient administration of high‐dose cisplatin
Background/Aims: Treatment with high‐dose cisplatin (HDC) previously required inpatient (IP) admission with overnight hospitalization, but recently practice has shifted to outpatient (OP) therapy. We aimed to determine whether it is preferable to give HDC as an IP or OP using a two‐period cross‐over trial.
No Supplementary Data
Document Type: Research Article
Publication date: 2011-02-01